Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10226-10231
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10226
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10226
Table 2 Changes in liver function tests
Genotype 1 | Genotype 2 | Genotype 3 | |||||||
Start Tx | End Tx | P value | Start Tx | End Tx | P value | Start Tx | End Tx | P value | |
Albumin (g/dL) | 3.5 ± 0.6 | 3.8 ± 0.6 | < 0.001 | 3.5 ± 0.5 | 3.7 ± 0.6 | < 0.002 | 3.4 ± 0.5 | 3.7 ± 0.6 | < 0.001 |
ALT (U/L) | 70.2 ± 58.3 | 31.7 ± 38.7 | < 0.001 | 68.7 ± 48.3 | 26.4 ± 17.8 | < 0.001 | 101.9 ± 61.6 | 30.7 ± 30.3 | < 0.001 |
Total Bilirubin (mg/dL) | 1.0 ± 0.8 | 0.9 ± 0.8 | 0.008 | 1.0 ± 0.9 | 0.9 ± 0.9 | 0.202 | 1.1 ± 0.7 | 1.1 ± 0.8 | 0.904 |
INR | 1.1 ± 0.2 | 1.1 ± 0.3 | 0.112 | 1.1 ± 0.1 | 1.0 ± 0.1 | < 0.001 | 1.1 ± 0.2 | 1.1 ± 0.3 | 0.509 |
- Citation: Pedersen MR, Patel A, Backstedt D, Choi M, Seetharam AB. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World J Gastroenterol 2016; 22(46): 10226-10231
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10226